Published in N Engl J Med on September 12, 2002
Effect of Dapagliflozin on Nighttime Blood Pressure in Type 2 Diabetes | NCT03887416
Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ (2004) 2.62
Cardiac autonomic neuropathy in diabetes: a clinical perspective. Diabetes Care (2010) 2.43
Ambulatory blood pressure and increased left ventricular mass in children at risk for hypertension. J Pediatr (2007) 2.00
Assessment and management of blood-pressure variability. Nat Rev Cardiol (2013) 1.84
Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study. Diabetes (2009) 1.76
Alterations of blood pressure in type 1 diabetic children and adolescents. Pediatr Nephrol (2006) 1.56
Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association. Hypertension (2014) 1.55
Heart rate variability predicts ESRD and CKD-related hospitalization. J Am Soc Nephrol (2010) 1.46
Should mean arterial pressure be included in the definition of ambulatory hypertension in children? Pediatr Nephrol (2013) 1.41
White-coat and masked hypertension in children: association with target-organ damage. Pediatr Nephrol (2005) 1.24
Assessment and management of hypertension in children and adolescents. Nat Rev Cardiol (2010) 1.20
Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management. Adv Chronic Kidney Dis (2011) 1.18
What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes. J Cardiovasc Transl Res (2012) 1.17
Prognostic value of blood pressure variability and average blood pressure levels in patients with hypertension and diabetes. Diabetes Care (2013) 1.16
Oxidative stress in hypertension: role of the kidney. Antioxid Redox Signal (2013) 1.13
Regulation of circadian blood pressure: from mice to astronauts. Curr Opin Nephrol Hypertens (2010) 1.02
Reversed dipper blood-pressure pattern is closely related to severe renal and cardiovascular damage in patients with chronic kidney disease. PLoS One (2013) 1.01
PPARalpha activation elevates blood pressure and does not correct glucocorticoid-induced insulin resistance in humans. Am J Physiol Endocrinol Metab (2006) 1.00
Sickle cell nephropathy: challenging the conventional wisdom. Pediatr Nephrol (2011) 0.99
Intima-media thickness measurements in children with cardiovascular risk factors. Pediatr Nephrol (2008) 0.99
The role of blood pressure variability in the development of nephropathy in type 1 diabetes. Diabetes Care (2010) 0.99
Proximal tubular angiotensinogen in renal biopsy suggests nondipper BP rhythm accompanied by enhanced tubular sodium reabsorption. J Hypertens (2012) 0.97
Relationship between ambulatory BP and clinical outcomes in patients with hypertensive CKD. Clin J Am Soc Nephrol (2012) 0.97
Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study. Diabetologia (2009) 0.95
Ambulatory blood pressure measurements are related to albumin excretion and are predictive for risk of microalbuminuria in young people with type 1 diabetes. Diabetologia (2009) 0.94
Spontaneously reduced blood pressure load in the rat streptozotocin-induced diabetes model: potential pathogenetic relevance. Am J Physiol Renal Physiol (2006) 0.94
Type 1 diabetes and cardiovascular disease. Cardiovasc Diabetol (2013) 0.94
Masked Uncontrolled Hypertension in CKD. J Am Soc Nephrol (2015) 0.94
Office and ambulatory blood pressure elevation in children with chronic renal failure. Pediatr Nephrol (2002) 0.94
Resting heart rate and the risk of microvascular complications in patients with type 2 diabetes mellitus. J Am Heart Assoc (2012) 0.92
Diabetic nephropathy in children and adolescents. Pediatr Nephrol (2007) 0.92
Persistence of circadian variation in arterial blood pressure in beta1/beta2-adrenergic receptor-deficient mice. Am J Physiol Regul Integr Comp Physiol (2008) 0.91
Intact renal afferent arteriolar autoregulatory responsiveness in db/db mice. Am J Physiol Renal Physiol (2008) 0.91
Hyperglycemia and renin-dependent hypertension synergize to model diabetic nephropathy. J Am Soc Nephrol (2011) 0.90
An Update on the Use of Animal Models in Diabetic Nephropathy Research. Curr Diab Rep (2016) 0.89
Should 24-h ambulatory blood pressure monitoring be done in every patient with diabetes? Diabetes Care (2009) 0.88
Pitfalls in the measurement of the nocturnal blood pressure dip in adolescents with type 1 diabetes. Diabetes Care (2008) 0.88
Nighttime hospital blood pressure--a predictor of death, ESRD, and decline in GFR. Ren Fail (2010) 0.87
Clinical relevance of visit-to-visit blood pressure variability: impact on renal outcomes. J Hum Hypertens (2013) 0.87
Disturbed circadian rhythm of the intrarenal renin-angiotensin system: relevant to nocturnal hypertension and renal damage. Clin Exp Nephrol (2014) 0.87
Implications for kidney disease in obese children and adolescents. Pediatr Nephrol (2011) 0.87
Implications of nocturnal hypertension in children and adolescents with type 1 diabetes. Diabetes Care (2011) 0.86
A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease. Hypertension (2012) 0.86
Nocturnal blood pressure fall as predictor of diabetic nephropathy in hypertensive patients with type 2 diabetes. Cardiovasc Diabetol (2010) 0.85
Masked hypertension is prevalent in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol (2012) 0.85
Cardiac autonomic neuropathy and early progressive renal decline in patients with nonmacroalbuminuric type 1 diabetes. Clin J Am Soc Nephrol (2015) 0.84
Ambulatory blood pressure monitoring in diabetes and obesity-a review. Int J Hypertens (2011) 0.84
Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study. Hypertension (2016) 0.84
NADPH oxidase and PKC contribute to increased Na transport by the thick ascending limb during type 1 diabetes. Hypertension (2011) 0.83
β2 adrenergic receptor polymorphisms and nocturnal blood pressure dipping status in the Wisconsin Sleep Cohort Study. J Am Soc Hypertens (2011) 0.83
Diabetic nephropathy - Epidemiology in Asia and the current state of treatment. Indian J Nephrol (2011) 0.83
Mitigating micro-and macro-vascular complications of diabetes beginning in adolescence. Vasc Health Risk Manag (2009) 0.83
Bedtime administration of long-acting antihypertensive drugs restores normal nocturnal blood pressure fall in nondippers with essential hypertension. Clin Exp Nephrol (2009) 0.83
Morning hypertension and night non-dipping in patients with diabetes and chronic kidney disease. Hypertens Res (2015) 0.83
Arterial hypertension in diabetes mellitus: from theory to clinical practice. Hippokratia (2008) 0.82
The Prevalence of Pre-hypertension in Children with Type 1 Diabetes Mellitus. Int J Prev Med (2014) 0.82
Non-dipper status and left ventricular hypertrophy as predictors of incident chronic kidney disease. J Korean Med Sci (2011) 0.81
Primary non-alcoholic fatty liver disease in hypertensive patients. Australas Med J (2013) 0.81
Assessment of the relation between mean platelet volume, non-dipping blood pressure pattern, and left ventricular mass index in sustained hypertension. Med Sci Monit (2014) 0.81
Metabolic cycles are linked to the cardiovascular diurnal rhythm in rats with essential hypertension. PLoS One (2011) 0.80
Albuminuria, renal dysfunction and circadian blood pressure rhythm in older men: a population-based longitudinal cohort study. Clin Kidney J (2015) 0.80
Treatment of hypertension in patients with diabetes mellitus : relevance of sympathovagal balance and renal function. Clin Res Cardiol (2007) 0.80
Recognition and Management of Resistant Hypertension. Clin J Am Soc Nephrol (2016) 0.80
The definition of daytime and nighttime influences the interpretation of ABPM in children. Pediatr Nephrol (2011) 0.79
Diabetic kidney disease; review of the current knowledge. J Renal Inj Prev (2013) 0.79
Ambulatory blood pressure monitoring: a versatile tool for evaluating and managing hypertension in children. Pediatr Nephrol (2008) 0.79
Baroreflex sensitivity and its response to deep breathing predict increase in blood pressure in type 1 diabetes in a 5-year follow-up. Diabetes Care (2011) 0.78
Increase in nocturnal blood pressure and progression to microalbuminuria in diabetes. N Engl J Med (2003) 0.78
Study of ambulatory blood pressure in diabetic children: prediction of early renal insult. Ther Clin Risk Manag (2015) 0.78
Variations in 7-day/24-h circadian pattern of ambulatory blood pressure and heart rate of type 2 diabetes patients. J Diabetes Investig (2014) 0.77
Twenty-four hour ambulatory blood pressure monitoring in adolescents with type 1 diabetes: getting started. J Diabetes Sci Technol (2008) 0.77
Awaking Blood Pressure Surge and Progression to Microalbuminuria in Type 2 Normotensive Diabetic Patients. J Diabetes Res (2015) 0.77
Increase in nocturnal blood pressure and progression to microalbuminuria in diabetes. N Engl J Med (2003) 0.77
The complex relationship between CKD and ambulatory blood pressure patterns. Adv Chronic Kidney Dis (2015) 0.77
Is nocturnal blood pressure reduction the secret to reducing the rate of progression of hypertensive chronic kidney disease? Curr Hypertens Rep (2011) 0.77
Pediatric ambulatory blood pressure monitoring: diagnosis of hypertension. Pediatr Nephrol (2013) 0.77
Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets. J Diabetes Res (2015) 0.77
Increase in nocturnal blood pressure and progression to microalbuminuria in diabetes. N Engl J Med (2003) 0.76
Evaluation of dosing time-related anti-hypertensive efficacy of valsartan in patients with type 2 diabetes. Clin Exp Hypertens (2010) 0.76
Treatment of hypertension in patients with nondiabetic chronic kidney disease. Can J Cardiol (2007) 0.76
Glucocorticoids Induce Nondipping Blood Pressure by Activating the Thiazide-Sensitive Cotransporter. Hypertension (2016) 0.76
Short-term reproducibility of ambulatory blood pressure monitoring in autosomal dominant polycystic kidney disease. Blood Press Monit (2011) 0.76
Effect of insulin on ACE2 activity and kidney function in the non-obese diabetic mouse. PLoS One (2014) 0.76
Telemedicine home blood pressure measurements and progression of albuminuria in elderly people with diabetes. Hypertension (2008) 0.76
Renal histopathology of a baboon model with type 2 diabetes. Toxicol Pathol (2012) 0.76
A pilot study on the effect of telmisartan & ramipril on 24 h blood pressure profile & dipping pattern in type 1 diabetes patients with nephropathy. Indian J Med Res (2011) 0.75
Cardiovascular changes during chronic hypertensive states. Pediatr Nephrol (2013) 0.75
Endocan and Non-Dipping Circadian Pattern in Newly Diagnosed Essential Hypertension. Korean Circ J (2016) 0.75
Association Between Blood Pressure and Adverse Renal Events in Type 1 Diabetes. Diabetes Care (2016) 0.75
Ambulatory blood-pressure monitoring as a predictive tool. N Engl J Med (2002) 0.75
Long-term effects of kidney donation on renal function and blood pressure in African Americans. Clin J Am Soc Nephrol (2011) 0.75
Prevalence of diabetic nephropathy among Type 2 diabetic patients in some of the Arab countries. Int J Health Sci (Qassim) (2017) 0.75
Prognostic Value of Reverse Dipper Blood Pressure Pattern in Chronic Kidney Disease Patients not Undergoing Dialysis: Prospective Cohort Study. Sci Rep (2016) 0.75
Mechanism of hypertension in diabetic nephropathy. J Nephropharmacol (2014) 0.75
Nocturnal blood pressure non-dipping is not associated with increased left ventricular mass index in hypertensive children without end-stage renal failure. Eur J Pediatr (2016) 0.75
Renal disease pathophysiology and treatment: contributions from the rat. Dis Model Mech (2016) 0.75
Prehypertension in adolescents with cardiovascular risk: a comparison between type 1 diabetic patients and overweight subjects. BMC Res Notes (2016) 0.75
Increase in nocturnal blood pressure and progression to microalbuminuria in diabetes. N Engl J Med (2003) 0.75
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens (2003) 5.94
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens (2009) 4.87
European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens (2013) 4.28
Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension (2009) 3.93
European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens (2008) 3.32
Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens (2005) 3.15
Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens (2009) 3.13
Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med (2003) 2.94
Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J Hypertens (2009) 2.68
2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension. Blood Press (2013) 2.62
Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes. J Am Soc Nephrol (2006) 2.41
Added impact of obesity and insulin resistance in nocturnal blood pressure elevation in children and adolescents. Hypertension (2008) 2.31
ESH position paper: renal denervation - an interventional therapy of resistant hypertension. J Hypertens (2012) 2.24
Antiproteinuric effect of oral paricalcitol in chronic kidney disease. Kidney Int (2005) 2.19
Predominance of AT(1) blockade over mas-mediated angiotensin-(1-7) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis rats. Am J Hypertens (2013) 2.11
Ambulatory blood pressure values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET). Hypertension (2012) 2.02
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press (2009) 1.98
Carotid-femoral pulse wave velocity assessment by two different methods: implications for risk assessment. J Hypertens (2015) 1.98
Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD. Am J Kidney Dis (2006) 1.97
Antihypertensive activity of angiotensin II AT1 receptor antagonists: a systematic review of studies with 24 h ambulatory blood pressure monitoring. J Hypertens (2007) 1.86
Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET). Circulation (2011) 1.77
Microvascular brain damage with aging and hypertension: pathophysiological consideration and clinical implications. J Hypertens (2011) 1.76
Blood pressure and obesity exert independent influences on pulse wave velocity in youth. Hypertension (2012) 1.70
Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice. Kidney Int (2012) 1.67
ACE and ACE2 activity in diabetic mice. Diabetes (2006) 1.66
Influence of concurrent obesity and low birth weight on blood pressure phenotype in youth. Hypertension (2009) 1.64
Prevalence, persistence, and clinical significance of masked hypertension in youth. Hypertension (2005) 1.61
European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens (2014) 1.58
Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism. Kidney Int (2003) 1.53
Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension. Hypertension (2009) 1.52
Associations of birth weight and postnatal weight gain with cardiometabolic risk parameters at 5 years of age. Hypertension (2014) 1.52
Association of central and peripheral pulse pressure with intermediate cardiovascular phenotypes. J Hypertens (2012) 1.49
Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination? Hypertension (2004) 1.48
2016 European Guidelines on cardiovascular disease prevention in clinical practice. Rev Esp Cardiol (Engl Ed) (2016) 1.42
Regression of left ventricular hypertrophy and microalbuminuria changes during antihypertensive treatment. J Hypertens (2013) 1.39
[Renal function as a prognostic marker of mortality in heart failure]. Med Clin (Barc) (2009) 1.38
Low mortality and key aspects of delivery of care for end-stage renal disease in Italy. ScientificWorldJournal (2009) 1.37
High CO2 levels impair alveolar epithelial function independently of pH. PLoS One (2007) 1.33
Proximal renal tubular acidosis: a not so rare disorder of multiple etiologies. Nephrol Dial Transplant (2012) 1.31
Genetic causes and mechanisms of distal renal tubular acidosis. Nephrol Dial Transplant (2012) 1.23
Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conference. Kidney Int (2009) 1.16
Ultrafiltration and small solute transport at initiation of PD: questioning the paradigm of peritoneal function. Perit Dial Int (2005) 1.15
Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients. Kidney Int (2003) 1.11
Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis. Virchows Arch (2004) 1.06
Apelin and ACE2 in cardiovascular disease. Curr Opin Investig Drugs (2010) 1.03
Birth weight impacts on wave reflections in children and adolescents. Hypertension (2002) 1.01
Regulation of urinary ACE2 in diabetic mice. Am J Physiol Renal Physiol (2013) 0.99
Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in Spain: the MERENA observational cohort study. BMC Nephrol (2011) 0.99
Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan. Am J Physiol Renal Physiol (2008) 0.98
Evaluation of renal hypoxia in diabetic mice by BOLD MRI. Invest Radiol (2010) 0.96
The GTP-binding protein RhoA mediates Na,K-ATPase exocytosis in alveolar epithelial cells. Mol Biol Cell (2003) 0.95
Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study. J Hypertens (2013) 0.94
The impact of the degree of obesity on the discrepancies between office and ambulatory blood pressure values in youth. J Hypertens (2006) 0.93
Evaluation and management of hyponatremia: an emerging role for vasopressin receptor antagonists. Nat Clin Pract Nephrol (2007) 0.93
Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitro. Hypertension (2014) 0.93
Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group 'Hypertension Arrhythmias and Thrombosis' of the European Society of Hypertension. J Hypertens (2012) 0.93
What the interventionalist should know about renal denervation in hypertensive patients: a position paper by the ESH WG on the interventional treatment of hypertension. EuroIntervention (2014) 0.92
Common variants of the liver fatty acid binding protein gene influence the risk of type 2 diabetes and insulin resistance in Spanish population. PLoS One (2012) 0.92
Effect of calcium-sensing receptor activation in models of autosomal recessive or dominant polycystic kidney disease. Nephrol Dial Transplant (2008) 0.92
European Society of Hypertension Working Group on Obesity Obesity-induced hypertension and target organ damage: current knowledge and future directions. J Hypertens (2009) 0.91
Na+/H+ exchange activity and NHE-3 expression in renal tubules from the spontaneously hypertensive rat. Kidney Int (2002) 0.91
[ESH/ESC 2007 Guidelines for the management of arterial hypertension]. Rev Esp Cardiol (2007) 0.90
New experimental models of diabetic nephropathy in mice models of type 2 diabetes: efforts to replicate human nephropathy. Exp Diabetes Res (2012) 0.89
The role of comprehensive renal clinic in chronic kidney disease stabilization and management: The Northwestern experience. Semin Nephrol (2002) 0.88
Inadequate cytoplasmic antioxidant enzymes response contributes to the oxidative stress in human hypertension. Am J Hypertens (2007) 0.88
Xanthine oxidoreductase polymorphisms: influence in blood pressure and oxidative stress levels. Pharmacogenet Genomics (2007) 0.86
Renin polymorphisms and haplotypes are associated with blood pressure levels and hypertension risk in postmenopausal women. J Hypertens (2008) 0.86
Determinants of urinary albumin excretion reduction in essential hypertension: A long-term follow-up study. J Hypertens (2006) 0.85
Acute renal failure and severe hypertension from a page kidney post-transplant biopsy. ScientificWorldJournal (2010) 0.85
Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence. J Hypertens (2014) 0.85
New developments in the pathogenesis of obesity-induced hypertension. J Hypertens (2015) 0.84
Association of a mineralocorticoid receptor gene polymorphism with hypertension in a Spanish population. Am J Hypertens (2009) 0.84
Agreement within Europe about antihypertensive treatment and education - results from the European Society of Hypertension questionnaire. J Hypertens (2010) 0.84
2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens (2016) 0.83
Updated ESH position paper on interventional therapy of resistant hypertension. EuroIntervention (2013) 0.83
Stabilization of glomerular filtration rate in advanced chronic kidney disease: a two-year follow-up of a cohort of chronic kidney disease patients stages 4 and 5. Adv Chronic Kidney Dis (2007) 0.83
Are physicians underestimating the challenges of hypertension management? Results from the Supporting Hypertension Awareness and Research Europe-wide (SHARE) survey. Eur J Prev Cardiol (2012) 0.83
Nocturnal blood pressure versus nondipping pattern: what do they mean? Hypertension (2007) 0.83
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke. J Hypertens (2016) 0.83
Acute renal failure from adulteration of milk with melamine. ScientificWorldJournal (2008) 0.83
Acid-base and potassium disorders in liver disease. Semin Nephrol (2006) 0.83
TWEAK transactivation of the epidermal growth factor receptor mediates renal inflammation. J Pathol (2013) 0.82
Rationale and methods of the cardiometabolic Valencian study (Escarval-Risk) for validation of risk scales in Mediterranean patients with hypertension, diabetes or dyslipidemia. BMC Public Health (2010) 0.82
A comparison of dosing regimens of paricalcitol capsule for the treatment of secondary hyperparathyroidism in CKD stages 3 and 4. Am J Nephrol (2006) 0.82
Polymorphisms of the UCP2 gene are associated with body fat distribution and risk of abdominal obesity in Spanish population. Eur J Clin Invest (2011) 0.82
ACE2 deficiency increases NADPH-mediated oxidative stress in the kidney. Physiol Rep (2014) 0.82
Predicting the development of diabetic nephropathy and its progression. Adv Chronic Kidney Dis (2005) 0.82
Pharmacologic modulation of ACE2 expression. Curr Hypertens Rep (2008) 0.82
Measurement of microalbuminuria--what the nephrologist should know. Nephrol Dial Transplant (2005) 0.81